The We Work revisited story continues to get commentary given the massive investment made by Andreesen Horowitz. It’s true that Adam Neuman built a game-changing real estate business. They re-defined
“If you owe the bank $100, that is your problem. If you owe the bank $100 Million, that’s the bank’s problem.” – John Paul Getty On wall street there is
In the introductory post on EOS, we shared the two key roles in this system – the Visionary and the Integrator. The Integrator is the more challenging role in many
Managed Syndicates for investors by Michael Schmanske Okay so we’ve covered “What are Managed Syndicates?” How about “WHY are Managed Syndicates?” For Investors in early stage startups you have a
The statistics surrounding the success of a startup are daunting. Based on the math, you are far more likely to fail than to succeed. The flip side of the same
Syndicates: A Primer by Michael Schmanske Special Purpose Vehicles (SPV’s) are the smaller, older sibling of a product that made a huge splash last year, the Special Purpose Acquisition Company
An Investment Framework by Michael Schmanske Anyone who knows me, knows I have no choice but to be blunt. I spent the early part of my career in the trading
We are pleased to introduce MD Next magazine as the newest channel in the AngelMD OmniChannel suite to educate and entertain healthcare innovation stakeholders. The magazine will be a quarterly
CB Insights shared the fact that some of the larger venture firms, who also happen to do most of their work in large and later stage rounds, are being forced
Ai Medica makes it easy to create clinical and economic value from EHR data using evidence based medicine. They have built a platform on SMART on FHIR interoperability standards that
AngelMD is a large and growing healthcare innovation community connecting clinicians, startups, investors, Industry and other stakeholders.
AngelMD is a large and growing healthcare innovation community centered around clinician & startups with tools & education for both.